Kristyn Gumpper-Fedus, PhD, for refining a draft of the Figure into its final form
COVID-19 and selenium deficiency: a systematic review
The good news is that with GLP-1s, she can treat both obesity/overweight and these associated metabolic diseases
BPC-157 creates this environment by: Increasing vascularization in the treated area, ensuring oxygen and nutrient delivery Reducing inflammation that could otherwise impair cell survival Upregulating growth factor receptors on local cells, making them more responsive to PRP-derived signals In my practice, patients receiving PRP or stem cell injections for complex musculoskeletal conditions are routinely offered concurrent BPC-157 to maximize outcomes
While semaglutide fulfills the functions of endogenous GLP-1, it has a distinct albumen-binding structure for greater stability and a longer duration of action
Most people fail because they treat the surface while the root cause keeps driving the darkness back